Skip to content

EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial-1)

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521315-39-00
Acronym
GRWD0715-AS-01
Enrollment
20
Registered
2025-10-06
Start date
2025-11-05
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axial spondyloarthritis

Interventions

None listed

Sponsors

Grey Wolf Therapeutics Limited
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Belgium, Germany, Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026